Dendritic Cell (DC) therapy represents a
promising immunotherapeutic approach for the treatment of cancer.
The beauty of DC therapy is that it exploits the body's own immune
system to fight cancer. Since 1997 we perform clinical trials to
test the potency of this approach. For each patient a specialized
vaccine is prepared from immune cells isolated from the blood. In
specialized cleanrooms, a personalized DC vaccine is prepared after
which patients are vaccinated. For more details on the DC
vaccination procedure see
this movie. So far, our clinical trials are mainly focused on
melanoma, a cancer of the pigmented cells of the skin. We have
treated more than 350 patients until now and observed that DC
vaccination is well tolerated with minimal side effects. If you are
interested in further information, Dutch patients can consult the
Dutch www site. Of
course you can always consult your physician.